Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. - Wikidata - awgldk - TriplyDB

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

http://www.wikidata.org/entity/Q46391119

about

Task shifting for scale-up of HIV care: evaluation of nurse-centered antiretroviral treatment at rural health centers in Rwanda Convergence of mortality rates among patients on antiretroviral therapy in South Africa and North America Attrition among human immunodeficiency virus (HIV)- infected patients initiating antiretroviral therapy in China, 2003-2010 Provision of antiretroviral treatment in conflict settings: the experience of Médecins Sans Frontières The spread, treatment, and prevention of HIV-1: evolution of a global pandemic Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies Prevention of HIV-1 infection with early antiretroviral therapy Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review The effect of tuberculosis treatment at combination antiretroviral therapy initiation on subsequent mortality: a systematic review and meta-analysis New pandemics: HIV and AIDS, HCV and chronic hepatitis, influenza virus and flu Probing Lipophilic Adamantyl Group as the P1-Ligand for HIV-1 Protease Inhibitors: Design, Synthesis, Protein X-ray Structural Studies, and Biological Evaluation Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration Predictors of tuberculosis in first 6 months after initiation of antiretroviral therapy: a case-control study Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal Virologic, immunologic and clinical responses in foreign-born versus US-born HIV-1 infected adults initiating antiretroviral therapy: an observational cohort study Comparison of tenofovir, zidovudine, or stavudine as part of first-line antiretroviral therapy in a resource-limited-setting: a cohort study Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi Reduction of maternal mortality with highly active antiretroviral therapy in a large cohort of HIV-infected pregnant women in Malawi and Mozambique Determinants of progression to AIDS and death following HIV diagnosis: a retrospective cohort study in Wuhan, China Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, Mozambique Incidence of AIDS-Defining Opportunistic Infections and Mortality during Antiretroviral Therapy in a Cohort of Adult HIV-Infected Individuals in Hanoi, 2007-2014 CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South Africa Association of adherence support and outreach services with total attrition, loss to follow-up, and death among ART patients in sub-Saharan Africa Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean Social and behavioral interventions for improving quality of life of HIV infected people receiving antiretroviral therapy: a systematic review and meta-analysis HIV epidemiology and the effects of antiviral therapy on long-term consequences.Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.NGO-provided free HIV treatment and services in Burkina Faso: scarcity, therapeutic rationality and unfair process.High early mortality in patients with chronic acquired immunodeficiency syndrome diarrhea initiating antiretroviral therapy in Haiti: a case-control study HIV-related stigma, isolation, discrimination, and serostatus disclosure: a global survey of 2035 HIV-infected adults.Morbidity and Mortality Patterns of Hospitalised Adult HIV/AIDS Patients in the Era of Highly Active Antiretroviral Therapy: A 4-year Retrospective Review from Zaria, Northern Nigeria.Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration

P2860

Q21034168-7C816B4F-2772-43BF-9845-9A2B364618A3 Q21034185-FDBF65FE-06F2-4100-B7C6-F2CCF42BD263 Q21134515-CC5469A8-907F-4C6D-B0C4-04C75151F4C8 Q21202765-658936DC-90EC-4AD5-A52E-CD48ED882475 Q22241890-168368CA-DFC5-4384-B0BC-87E3E9E80F22 Q24235883-F2221C48-EFFB-479A-8429-60BD48AFED8A Q24597052-B7ABD42F-1B80-44D1-B8DE-948ACB177236 Q24634688-A3EC56D8-ADEB-4B41-B23D-E6E833E685F0 Q24656950-4B204F5A-0237-49C0-A7AF-9789F0DD9E3C Q26823588-19F40030-542B-43E3-8E84-7633858BB71F Q27014121-E88DB9A1-DCF9-44AD-A955-F737F25B0EF4 Q27478093-45370606-9B1E-4C29-BEC1-FF6979C3FA0D Q27717366-59398D99-51C8-4987-AD4D-E7DFEEA3EDB2 Q28222847-E57607A0-B4B6-488E-97FE-69B85C53F752 Q28397102-54DF3F0A-E761-4FB7-951E-44CFFB0D052A Q28472043-C8F44A6B-542A-4AC8-B99E-322EAFD48012 Q28473120-B56E3B68-4A4D-4218-B28A-491093C75221 Q28475331-3068DEDC-091A-4331-AEEF-457F9DC5F87B Q28475790-71CB2CF7-5135-4A4F-840B-613CCF39AEBB Q28476337-401AED16-AE03-43A1-B830-3AD2994C0BDC Q28484434-36A61DD8-7257-4094-A819-66E261FA13F9 Q28487986-426D7E3A-409B-4185-931B-427FC7490658 Q28533819-1DF32C61-6A5F-45F1-AE24-9FAAB8910D8D Q28535436-84092D87-760E-43C3-8953-7AA5B034E8EC Q28537961-07574271-C3C9-4EBA-87CC-235A1D806087 Q28546341-65F05D02-1623-4446-9857-E98F1138AA32 Q28550534-0595087E-94BA-4E3E-92F5-FEA28B5E4356 Q28703565-A90D9D3D-62E9-4A72-83B0-48F30A60BF9B Q28728715-81439265-96E9-4F04-BB90-B4B6BEAEE9DC Q28730824-3A1BDF96-9806-4ED9-A544-3F10AABBF53A Q28731034-95856028-E9D2-4935-B427-E7EDB00275D1 Q28749991-15189F0A-E23B-4D42-9E1A-9EE412B7C96C Q30234684-AE5B969C-6F62-4B40-A2E7-36A08C01E989 Q30372536-0ECEF90E-6816-48CB-BE0A-E33D6658FAD3 Q30409179-A0A2E2D6-B323-4587-A038-0BFAC5481E83 Q30413878-381BDE67-88A6-42AE-8E0F-FBEE6D7F54B8 Q30414385-78215005-49BA-4B24-AB07-9383665F3DBD Q30414449-29FD70DE-4AC9-4221-B415-6A1DA7F07150 Q30421741-987ED6B7-A773-4921-AFB6-6D246AAB6087 Q30583563-223165ED-95BF-4408-BEDD-40984A17C4A0

P2860

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

http://www.wikidata.org/entity/Q46391119

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Mortality of HIV-1-infected pa ...... ome and high-income countries.

@en

Mortality of HIV-1-infected pa ...... ome and high-income countries.

@nl

type

label

Mortality of HIV-1-infected pa ...... ome and high-income countries.

@en

Mortality of HIV-1-infected pa ...... ome and high-income countries.

@nl

prefLabel

Mortality of HIV-1-infected pa ...... ome and high-income countries.

@en

Mortality of HIV-1-infected pa ...... ome and high-income countries.

@nl

P1433

Q46391119-E88FF448-5429-43AB-9636-81C05C2C2BE1

P1476

Q46391119-35F4D939-1481-49F8-90CA-89042C967A5F

P2093

Q46391119-36B82C3E-FC6B-4AC7-891A-8A1FF016B8CF

Q46391119-4EA14C2A-9880-4DC2-8B7F-D7EC3630E4DB

Q46391119-5015DE33-EA2E-4A3A-91BF-DEFC3FA71185

Q46391119-575B2E31-850D-4DA3-BD20-ACC333DB0828

Q46391119-57F02588-8FD6-4564-AF68-E3658FD22B17

Q46391119-79F97160-22B5-4897-B293-4B9E27FFB28F

Q46391119-8FC15D4D-DF8E-4A12-BAB8-AD4EF3571E3B

Q46391119-98404F0B-34DB-4C85-A08B-63774E5B91DE

Q46391119-C18A5BDF-FA8D-44AB-9348-260815B3D3C3

Q46391119-C30B5536-E9B0-43AA-B1B1-E82FBCAD25C0

P304

Q46391119-8448AE4C-06A0-4DF0-B40B-711C6559CC98

P31

Q46391119-5423E61E-4181-4108-8523-A1CC299AA86F

P356

Q46391119-0FEF87AA-F217-4C63-81B4-8937313DE0C0

P407

Q46391119-26247894-4D84-44B8-BE45-8F2FCF35D337

P433

Q46391119-134F29FA-750C-4ACE-9699-2C831EB8F6BC

P478

Q46391119-B2B55217-DE1E-4A67-960A-7B620553C77C

P50

Q46391119-1B5473B9-9EE8-4DB5-BC99-10AA413C8375

Q46391119-238DA719-A14E-4604-BA8F-11ADA4C4C1E1

Q46391119-30E8BDF5-3271-4401-8E72-4A900A5851A0

Q46391119-64448751-F9C5-4B8F-A71F-59EA575B573E

Q46391119-86B1E0E9-F8FB-4A49-ADB7-CA4C01789179

Q46391119-A5933088-C7F3-4FDC-8B1E-7E5BE3911F9C

P577

Q46391119-8E9DC5F1-E3E1-4EC1-8B81-C460BA7BA08E

P5875

Q46391119-1EB4A832-7292-44AB-AF98-2CDC3DB223D0

P698

Q46391119-BC05DAE2-282B-410B-AE03-D57000BEDFF4

P921

Q46391119-2D0B466F-8F3C-482F-998F-3406925AEA88

Q46391119-D45EBD08-EECE-45D2-952F-933797E3A33A

P356

S0140-6736(06)68337-2

P1433

P1476

Mortality of HIV-1-infected pa ...... ome and high-income countries.

@en

P2093

ART Cohort Collaboration (ART-CC) groups

http://www.w3.org/2001/XMLSchema#string

Andrew Boulle

http://www.w3.org/2001/XMLSchema#string

Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration

http://www.w3.org/2001/XMLSchema#string

Catherine Seyler

http://www.w3.org/2001/XMLSchema#string

Christian Laurent

http://www.w3.org/2001/XMLSchema#string

Eduardo Sprinz

http://www.w3.org/2001/XMLSchema#string

Eric Balestre

http://www.w3.org/2001/XMLSchema#string

Jonathan A C Sterne

http://www.w3.org/2001/XMLSchema#string

Martin W G Brinkhof

http://www.w3.org/2001/XMLSchema#string

Mauro Schechter

http://www.w3.org/2001/XMLSchema#string

P304

817-824

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(06)68337-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

9513

http://www.w3.org/2001/XMLSchema#string

P478

367

http://www.w3.org/2001/XMLSchema#string

P50

François Dabis

David R Bangsberg

Paula Braitstein

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7247065

http://www.w3.org/2001/XMLSchema#string

P698

16530575

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug